Exelixis, Inc. (NASDAQ:EXEL) authorized repurchasing up to an additional $500 million of the company’s common stock before ...

Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that members of the executive team are scheduled to participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, ...

Studies from Munich University highlighted quality of life in bladder and prostate cancer at ASCO 2025 Genitourinary Cancers ...

Veritas Veterinary Partners ("Veritas"), one of the fastest-growing specialty and emergency veterinary services organizations in the world, today announced its expansion in California with the opening ...

Proton pump inhibitors and antibiotics increase mortality risk, while statins, renin-angiotensin system inhibitors.

Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for ...

Verrica Pharmaceuticals Inc.’s VRCA share price has surged by 13.02%, which has investors questioning if this is right time ...

Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today reported its financial results for ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) has reached an unprecedented milestone as its stock price soared to an ...

Breast cancer survivors who developed incident myocardial infarction or heart failure exhibited increased risk for adverse oncologic outcomes, according to a population-based cohort study.The findings ...

Cancer experts at Providence Saint Joseph Medical Center came together in the early 2000s with a common vision — to build one ...